Nandita Vijayasimha, Bengaluru Tuesday, June 3, 2025, 08:00 Hrs [IST] ...

Novartis announces phase III NATALEE trial of Kisqali reduces risk of recurrence in younger patients with early breast cancer: Basel Tuesday, June 3, 2025, 18:00 Hrs [IST] Novarti ...

Our Bureau, Mumbai Tuesday, June 3, 2025, 15:40 Hrs [IST] ...

Oliver Wyman appoints Dr Chirag Adatia as Partner in Health & Life Sciences and Private Capital practices: Our Bureau, Bengaluru Tuesday, June 3, 2025, 16:15 Hrs [IST] Oliver Wyma ...

DRI seizes 7 kg methamphetamine tablets worth in Tripura, two persons arrested: Our Bureau, New Delhi Tuesday, June 3, 2025, 15:15 Hrs [IST] The Directorate of Revenue Intelligenc ...

Indoco launches Ticagrelor film-coated tablets through its subsidiary in UK: Our Bureau, Bengaluru Tuesday, June 3, 2025, 15:50 Hrs [IST] Indoco announced that its subsidiary comp ...

Outlook Therapeutics introduces Lytenava in Germany & UK for the treatment of wet AMD: Iselin, New Jersey Tuesday, June 3, 2025, 16:00 Hrs [IST] Outlook Therapeutics, Inc., a biop ...

Glenmark's cancer drug delivers high response in phase-1 trial, shows 74% response: Our Bureau, Mumbai Tuesday, June 3, 2025, 16:45 Hrs [IST] Ichnos Glenmark Innovation (IGI), a g ...

TDB supports indigenous manufacturing of complex pharma excipients: Our Bureau, New Delhi Tuesday, June 3, 2025, 15:30 Hrs [IST] The Technology Development Board (TDB) under the D ...

Sanofi to acquire US-based biopharma company, Blueprint Medicines for up to $9.5 billion: Paris Tuesday, June 3, 2025, 09:00 Hrs [IST] Sanofi and Blueprint Medicines Corporation ( ...

Shardul Nautiyal, Mumbai Tuesday, June 3, 2025, 08:00 Hrs [IST] ...

Bayer seeks Japanese marketing authorization for low-dose contrast agent, gadoquatrane for contrast-enhanced MRI of all body regions and CNS: Berlin Tuesday, June 3, 2025, 13:00 H ...